Policy & Medicine - Legal, Regulatory, and Compliance Issues

Amy Greenstein, Senior Consultant and Dana Liu, Consultant, Polaris The PRC continues to focus on three principle life science…

In early March 2017, Senator Chuck Grassley sent a letter to the manufacturer of Auvi-Q (an epinephrine injector similar to…

The 340B Drug Discount Program plays an important role in the United States healthcare system by providing healthcare services…

Senator Claire McCaskill, Ranking Member of the Senate’s Homeland Security and Governmental Affairs Committee, has launched a…

President Donald Trump recently met with several Democratic lawmakers regarding rising drug prices, including Representative…

Moments before a scheduled vote on the bill, Republican House leaders announced that they were pulling the American Health Care…

On April 5, 2017, the Senate Health, Education, Labor, and Pensions (HELP) Committee held a confirmation hearing on the nomination…

With the close of Open Payments submission just behind us, the Centers for Medicare & Medicaid Services (CMS) plans to publish…

In an article published in Science Translation Medicine, Disciplined approach to drug discovery and early development, Robert…

In early December 2016, the Sapin II law was enacted in France. The law, which is meant to promote transparency, fight against…